CEO's Address to Shareholders
Filed with ASX · · 4 pages · English
Summary by 6ix AI
This filing is an address by Chief Executive Officer Mike Mathias to shareholders at Saluda Medical's annual meeting, detailing the company's achievements and future plans. The CEO highlighted significant revenue growth and advancements in their neuromodulation technology, particularly the FDA approval of a new product. He emphasized the company's commitment to expanding physician adoption and improving patient outcomes through innovative therapies.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Saluda Medical, Inc.(ASX:SLD, “Saluda” or the “Company”) will hold its Annual Meeting today at 11:30AM (AEDT). Attached is a copy of the address to be given by the Chief Executive Officer at the Annual Meeting. The above details are provided in accordance with rule 3.13.3 of the ASX Listing Rules. This announcement has been authorised for release by Saluda’s Disclosure Committee. For more informat
Earlier from Saluda Medical
- Director Appointment/Resignation
- Application for quotation of securities - SLD
- Quarterly Investor Presentation
- Quarterly Activity Report
- Quarterly Appendix 4C Cash Flow Report
Follow Saluda Medical into a list and get an email when it puts out news.
Follow Saluda Medical